Literature DB >> 21160574

Atherosclerosis, inflammation and Chlamydia pneumoniae.

Giovanni Fazio1, Maria Giovino, Alessandro Gullotti, Daniela Bacarella, Giuseppina Novo, Salvatore Novo.   

Abstract

Coronary heart disease is the single most common cause of illness and death in the developed world. Coronary atherosclerosis is by far the most frequent cause of ischemic heart disease, and plaque disruption with superimposed thrombosis is the main cause of the acute coronary syndromes of unstable angina, myocardial infarction, and sudden death. Atherosclerosis is the result of a complex interaction between blood elements, disturbed flow, and vessel wall abnormality, involving several pathological processes: inflammation, with increased endothelial permeability, endothelial activation, and monocyte recruitment; growth, with smooth muscle cell proliferation, migration, and matrix synthesis; degeneration, with lipid accumulation; necrosis, possibly related to the cytotoxic effect of oxidized lipid; calcification/ossification, which may represent an active rather than a dystrophic process; and thrombosis, with platelet recruitment and fibrin formation. In this review we discuss these processes and the possible pathological effects of Chlamydia infection and the ensuing phlogosis.

Entities:  

Keywords:  Chlamydia; Coronary atherosclerosis; Coronary heart disease; Phlogosis

Year:  2009        PMID: 21160574      PMCID: PMC2999038          DOI: 10.4330/wjc.v1.i1.31

Source DB:  PubMed          Journal:  World J Cardiol


  41 in total

Review 1.  Vulnerable atherosclerotic plaque: a multifocal disease.

Authors:  Ward Casscells; Morteza Naghavi; James T Willerson
Journal:  Circulation       Date:  2003-04-29       Impact factor: 29.690

2.  Association of infection with coronary artery disease.

Authors:  Rajesh Vijayvergiya
Journal:  Indian J Med Res       Date:  2007-02       Impact factor: 2.375

3.  Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions: a 5-year follow-up study.

Authors:  Egle Corrado; Manfredi Rizzo; Rosalba Tantillo; Ida Muratori; Francesca Bonura; Giustina Vitale; Salvatore Novo
Journal:  Stroke       Date:  2005-12-22       Impact factor: 7.914

Review 4.  The role of infection in the pathogenesis of cardiovascular disease.

Authors:  James S Zebrack; Jeffrey L Anderson
Journal:  Prog Cardiovasc Nurs       Date:  2003

5.  [Association between carotid atherosclerosis, inflammatory markers and Chlamydia pneumoniae infection].

Authors:  Radosław Kaźmierski; Edyta Podsiadły; Stanisława Tylewska-Wierzbanowska; Wojciech Kozubski
Journal:  Neurol Neurochir Pol       Date:  2005 Jul-Aug       Impact factor: 1.621

6.  Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis.

Authors:  M Davidson; C C Kuo; J P Middaugh; L A Campbell; S P Wang; W P Newman; J C Finley; J T Grayston
Journal:  Circulation       Date:  1998-08-18       Impact factor: 29.690

Review 7.  [Infection and coronary atherosclerosis: the role Chlamydia pneumonia].

Authors:  M Paz; J de Otero; P Codinach; F Ferrer-Ruscalleda; M Gayà; M Ibernón
Journal:  Rev Esp Cardiol       Date:  1998-11       Impact factor: 4.753

8.  Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology.

Authors:  José Zamorano; Avelina Suarez; Julio Garcia Tejada; Ester Culebras; Jose Castañón; Juan Picazo; Raúl Moreno; Luis Sanchez-Harguindey
Journal:  Int J Cardiol       Date:  2003-06       Impact factor: 4.164

9.  [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis].

Authors:  R Andrié; P Braun; U Welsch; E Straube; H W Höpp; E Erdmann; B Lüderitz; G Bauriedel
Journal:  Z Kardiol       Date:  2003-06

10.  Chlamydia pneumoniae in the atherosclerotic plaques of patients with unstable angina undergoing coronary artery bypass grafting: does it have prognostic implications?

Authors:  José Zamorano; Julio García-Tejada; Avelina Suárez; Esther Culebras; José Castañón; Raúl Moreno; Fernando Reguillo; Manuel Gil; Juan Picazo; Luis Sánchez-Harguindey
Journal:  Int J Cardiol       Date:  2003-08       Impact factor: 4.164

View more
  7 in total

1.  Influence of intimal Chlamydophila pneumoniae persistence on cardiovascular complications after coronary intervention.

Authors:  I Tuleta; D Reek; P Braun; G Bauriedel; G Nickenig; D Skowasch; R Andrié
Journal:  Infection       Date:  2014-10-26       Impact factor: 3.553

2.  Heart failure and chronic obstructive pulmonary disease: Two for tea or tea for two?

Authors:  Stanislav Suskovic; Mitja Kosnik; Mitja Lainscak
Journal:  World J Cardiol       Date:  2010-10-26

3.  The duration of Chlamydia muridarum genital tract infection and associated chronic pathological changes are reduced in IL-17 knockout mice but protection is not increased further by immunization.

Authors:  Dean W Andrew; Melanie Cochrane; Justin H Schripsema; Kyle H Ramsey; Samantha J Dando; Connor P O'Meara; Peter Timms; Kenneth W Beagley
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

4.  Productive and Penicillin-Stressed Chlamydia pecorum Infection Induces Nuclear Factor Kappa B Activation and Interleukin-6 Secretion In Vitro.

Authors:  Cory A Leonard; Robert V Schoborg; Nicole Borel
Journal:  Front Cell Infect Microbiol       Date:  2017-05-11       Impact factor: 5.293

5.  Is there any relationship between Chlamydophila pneumoniae and coronary atherosclerosis among Iranians?

Authors:  Mohammad Hadi Sadeghian; Seyed Abbas Tabatabaee Yazdi; Hossein Ayatollahi; Mohammad Reza Keramati; Kiarash Ghazvini; Ali Reza Rezai; Nasrin Heidari; Maryam Sheikhi; Gohar Shaghayegh
Journal:  Niger Med J       Date:  2013-01

6.  Chlamydia pneumoniae infection and cardiac risk factors in patients with myocardial infection.

Authors:  Zohreh Azarkar; Majid Jafarnejad; Mahmood Zaedast; Alireza Saadatjou; Parvaneh Portoghali
Journal:  ARYA Atheroscler       Date:  2011

7.  Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.

Authors:  Ildikó Lantos; Valéria Endrész; Dezső Péter Virok; Andrea Szabó; Xinjie Lu; Tímea Mosolygó; Katalin Burián
Journal:  Biomed Res Int       Date:  2018-03-25       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.